{"version":"1.0","type":"link","title":"Nonglycosylated, Legumain-Cleavable ISACs Drive Potent Antitumor Immunotherapy via a Bystander Effect.","author_name":"Zhang A 외","author_url":"https://prs-insight.online/author/Zhang%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/148901","thumbnail_width":1200,"thumbnail_height":630}